GLOBAL HEALTHCARE CONCLAVE GHC

5
DELEGATE BROCHURE GLOBAL HEALTHCARE CONCLAVE ONCOLOGY-2021 Australia - India - Malaysia - Singapore GHC ONCOLOGY THEME : "TECHNOLOGIES THAT SHAPE THE FUTURE OF CANCER CARE" DATE : 19 - 20 MAY, 2021 | ADELAIDE CONVENTION CENTRE LIVE STREAM: INDIA - MALAYSIA - SINGAPORE www.ghaonline.in/ghco/

Transcript of GLOBAL HEALTHCARE CONCLAVE GHC

D E L E G A T E B R O C H U R E

GLOBAL HEALTHCARE CONCLAVE ONCOLOGY-2021

Australia - India - Malaysia - SingaporeGHC

ONCOLOGY

THEME :

"TECHNOLOGIES THAT SHAPE THE FUTURE OF CANCER CARE"

DATE : 19 - 20 MAY, 2021 | ADELAIDE CONVENTION CENTRE

LIVE STREAM: INDIA - MALAYSIA - SINGAPORE

www.ghaonline.in/ghco/

Curing cancer is certainly one of the big challenges of the 21st century. Our knowledge of cancer has greatly improved in the last two decades. This has revealed the huge variability that can be found between not only different types of cancer, but also between patients with the same type of cancer. It seems increasingly evident that there won't be a single 'cure'. Rather, each patient will be treated accordingly to their specific needs. But for personalized medicine to become a reality, we need a range of therapies wide enough to cover the whole spectrum of cancer.

The New approaches to tame the immune system in the fight against cancer are getting us closer to a future where technology will change cancer care and becomes a curable disease. Personalized vaccines, cell therapy, gene editing and microbiome treatments and many such technologies will contribute substantially in cancer care.

About GHCO

Executive Chairman - HCG

Novel concepts have been emerging to improve the traditional therapeutic options in cancers, new therapeutic strategies involving areas like energy metabolism and extracellular vesicles along with advances in immunotherapy and nanotechnology are driving the next generation of cancer treatments. The development of fields such as theranostics, cancer therapeutics, emerging technologies, nanomedicine, computational imaging, cellular stress, radiosensitizing, exosomes, nanomedicine is also opening new doors for targeted drug delivery. Here we, Australia, India, Malaysia and Singapore come together to discuss how we can take a moon shot in technologies that can change the future of cancer care. We invite Government, Academia, Research Centres, Healthcare Organisations, Clinicians, Industry and VC to participate engage in these discussion which will lay a foundation for innovation in the region.

Dr. B S Ajaikumar Executive Chairman - HCG

Bengaluru, KarnatakaIndia

www.ghaonline.in/ghco/

www.ghaonline.in/ghco/

Committee Members

Dr Carsten PalmeChris o’ Brien Lifehouse,

Australia

Dr Ravi MehrotraICMR, India

Dr Vishal RaoHCG Hospitals,

India

Dr Mandar KulkarniVCR PARK,

India

Dr Jitendra KumarBangalore Bio

Innovation Centre, India

Mr Sujoy DeyCIMGlobal, Australia

Mr Ramchandra KowligiGHA, India

Mr Ramkumar VijayanCIMGlobal, Singapore

Ms. Meena DalalTrail Guna,

India

Dr Tamara LeclercqAdelaide BioMed City,

Australia

Chief Guests’

Prof (Dr) Steve WesselinghSAHMRI

Australia

Richard Harvey MPMember of Newland

South Australian ParliamentAustralia

Dr. B S AjaikumarExecutive Chairman - HCG

Bengaluru, KarnatakaIndia

Dr Johan VerjansSAHMRI

Australia

Dr Ashwath NarayanDeputy Chief Minister of

KarnatakaIndia

Prof N Gopalakrishna IyerHead & Senior Consultant

National Cancer CentreSingalore

Dr Amit RauthanIndia

Speakers

www.ghaonline.in/ghco/

Prof. Ambarish GhoshIndia

Dr C S PrameshIndia

Dr. Govind BabuIndia

Dr Hannah WardillAustralia

Dr Jugunu JainIndia

Dr Johan VerjansAustralia

Dr Jitendra Kumar India

Dr Joel GeogheganAustralia

Dr MeeshaChathurvedhi

india

Prof N Gopalakrishna Iyer Singapore

Dr Richard Harvey MP Australia

Dr Ravi MehrotraIndia

Professor Steve WesselinghAustralia

Dr Sanjay GargAustralia

Dr Vijay ChandruIndia

Dr Vishal RaoIndia

Dr. B S AjaikumarIndia

Prof Clive PrestidgeAustralia

Dr Carsten PalmeAustralia

Dr Mandar Kulkarni india

Dr Mark RoeAustralia

Dr Michael P. BrownAustralia

Dr Rahul NagadiaSingapore

Dr Surender Kumar DabasIndia

Dr Ujjwal RaoIndia

Dr Anthony Cole Australia

Prof David WatsonAustralia

Dr Gabriel MaicasAustralia

Prof Michael SorichAustralia

Dr Sathees RaghavanIndia

Our Partners

HCG Academics: HCG Centre for Academics and Research (HCG Academics in short) is the Academics and Research division of HCG Hospitals. HCG Hospitals comprises of chain of Hospitals and Clinics offering specialized services in the field of Oncology (Cancer care). (www.hcgacademics.com)

For more than 20 years, illumina has aspired to improve human health by unlocking the power of the genome. Now, through innovation and collaboration with pathologists, hematologists, and oncologists, we are enabling genomic breakthroughs in immunotherapy, biomarker discovery, and therapy selection. As we move towards precision medicine, we have only just begun to discover the true impact of genomics. Bring cancer into focus with comprehensive genomic profiling- simultaneously assess multiple biomarkers in numerous tumor types with a single NGS assay. (https://sapac.illumina.com/areas-of-interest/cancer/clinical-cancer-research/cgp.html)

RGUHS: Rajiv Gandhi University of Health Sciences, Karnataka a premier Health Science University in India was established on 1st June 1996 at Bangalore by the Govt. of Karnataka. RGUHS is considered one of the top universities offering the best medical education in India with initiatives to make its syllabi for different courses of world class quality taking it to the forefront of Medical education in India. www.rguhs.ac.in) (

JNCASR: Jawaharlal Nehru Centre for Advanced Scientific Research (JNCASR) is a multidisciplinary research institute situated in Jakkur, a locality north of Bangalore, India. It is relatively young yet well-known around the Globe. (www.jncasr.ac.in)

Trial Guna: Prosper as value, insight & performance driven clinical research and management organisation with an aim to consistently transform, impact and connect clinical research and their values not just medically but societally with a human aspect. (www.trialguna.com)

GHA: Global Healthcare Academy (GHA) has been instituted with the mission of is to develop Competent and Compassionate Human Resources for the Healthcare sector. Our core purpose is to bridge the skill & knowledge gap between formal education and needs of the Healthcare Industry. (www.ghaonline.in)

ICMR: The Indian Council of Medical Research, the apex body in India for the formulation, coordination, and promotion of biomedical research, is one of the oldest and largest medical research bodies in the world. (www.icmr.gov.in)

BBC: Bangalore Bioinnovation Centre (BBC) is a joint initiative of Department of Biotechnology, Government of India and Department of Electronics, IT, BT and S&T, Government of Karnataka. It works closely with Karnataka Innovation & Technology Society (KITS), a nodal centre for implementing schemes of the Department of Electronics, IT, BT and S&T, Government of Karnataka & its startup cell. (www.bioinnovationcentre.com)

Adelaide BioMed City: ndhi Adelaide BioMed City is a hub for health and life sciences. It co-locates institutions from research, education and clinical care in a precinct in the heart of Adelaide. Our mission is to be a globally recognised partnership leading in research, education, clinical care and population health. (www.adelaidebiomedcity.com)

SAHMRI: The South Australian Health and Medical Research Institute (SAHMRI) is South Australia's first independent flagship health and medical research institute. We're home to more than 700 medical researchers, working together to tackle the biggest health challenges in society today. (www.sahmri.org)

www.ghaonline.in/ghco/

Dr Anthony Cole Australia

Prof David WatsonAustralia

Dr Gabriel MaicasAustralia

Prof Michael SorichAustralia

Dr Sathees RaghavanIndia